Dhaval Shah · Healthcare Data, Analytics & AI Leader

Turn healthcare data into decisions that improve outcomes and financial performance.

One leadership model that connects advanced analytics, predictive models and AI to clinical, utilization and financial decisions. It runs on the BI and data platforms a health plan already owns, and it measures whether each action helped members and the business.

Analytics is the brain.AI is the accelerator.Outcomes are the proof.
WHO Dhaval K. Shah

Healthcare data, analytics & AI leader. 15+ years, starting with six at CareFirst BlueCross BlueShield. Today Engineering Manager, Data Analytics & AI at Magnit Global, leading a 9-person team serving 110+ enterprise clients.

LOOKING FOR

Director or Senior Manager, Data & Analytics, at health plans, providers and healthcare analytics companies. Engineering, analytics and AI are the capabilities I bring to that role.

THE 2-MINUTE TOUR
  1. Who I am: CareFirst to today
  2. How I think about analytics
  3. One working proof
  4. How I'd lead it at your organization

Delivered evidence of execution · Proposed evidence of thinking

01 · Who I am Delivered

I started in healthcare. The domain changed; the work and the ideas didn't.

Six years building claims, member and provider analytics at a Blue Cross Blue Shield plan. Then enterprise warehousing at one of the largest US staffing companies, and now leading a data platform team at Magnit Global. The same problems kept coming back: one trusted definition, one identity per member or supplier, governed data that leaders and AI can both use.

  1. 2010 – 2016 CareFirst BlueCross BlueShield Programmer Analyst II · healthcare payer

    Claims, member, eligibility, provider and clinical data from NASCO, Facets, EHR-related systems and provider applications. ICD-9/ICD-10 coding, PCMH analytics, and PHI handled under HIPAA.

  2. 2016 – 2019 Allegis Group Senior Data Engineer / DW Architect

    Enterprise warehouse with a bus matrix and conformed dimensions across business units; Informatica ETL across 10+ source systems; MDM golden-record and data-quality patterns.

  3. 2019 – today Magnit Global Engineering Manager, Data Analytics & AI

    A 9-person team and a platform serving 110+ enterprise clients. Snowflake platform live in production since May 2025; Power BI semantic layer with row-level security; AI on governed KPIs.

Delivered What I've actually led

15+years in data & analytics
May 2025Snowflake platform live in production
9engineers led today
110+enterprise clients served
~40%less effort to onboard a new client
100+reports migrated, zero client disruption

The same thread through every role Delivered

What the ideas needCareFirst · healthcareAllegisMagnit Global · today
AI on governed metricsIdea 01 SSRS and SSAS analytics used directly by healthcare leadership for operational and strategic decisions. KPIs and analytical models defined with business stakeholders and adopted across divisions. Snowflake Cortex pilot: analysts ask plain-English questions against governed KPI views, with accuracy evaluated before wider rollout.
One definition, every toolIdea 02 Type-2 SCD dimensional models for claims, member and provider data, used for historical trend analysis. Data Warehouse Bus Matrix with conformed dimensions and facts across business units. Lean Data Model: reusable business definitions and thin semantic models across 5+ VMS platforms, cutting onboarding effort ~40%. Centralized Power BI semantic layer replaced per-client reports.
Member & provider identityMember 360 · Provider 360 Integrated NASCO, Facets, EHR-related and provider systems into central data environments. Informatica MDM matching and golden-record patterns. AI-assisted MDM: supplier matching, hierarchy detection and metadata enrichment across systems.
Governed, trusted platformPHI · lineage · release control PHI handled under HIPAA with access control, reconciliation and auditing from development to production. Data-quality program with Informatica IDQ; CI/CD for warehouse releases. Snowflake Bronze/Silver/Gold with Kafka CDC and Fivetran ingestion, dbt, Airflow, row-level security and release governance. Oracle → PostgreSQL migration of 100+ reports with zero client disruption.
02 · How I think

Four capabilities, one decision system

Every use case on this page runs through the same loop. Pick a stage to see the question it answers.

Advanced analytics

Descriptive and diagnostic analytics explain cost, utilization, population, provider and clinical patterns. Statistical methods separate real movement from noise.

PMPM → utilization / unit cost → cohort / provider / site → clinical context
Predictive analytics & ML

Models help prioritize; they do not replace judgment. Risk stratification, forecasting and propensity surface emerging populations and likely future utilization.

History + context → model → risk / forecast → prioritized population
AI investigator

AI sits on top of governed analytics. It explains evidence, supports plain-language investigation and suggests the next analysis, while people stay responsible for decisions.

Question → governed evidence → explanation → next analysis → human review
Trusted Metrics Foundation

The foundation under all four: each metric is defined once, owned and certified, and served the same way to any BI tool, notebook, app or AI agent.

Define once → compile to any platform → serve to any tool
Program effectiveness

The loop closes by measuring intervention outcomes against a baseline across utilization, clinical outcomes and financial performance.

Baseline → intervention → outcome → attribution → learn
03 · One working proof Proposed · synthetic data

How I'd answer "why did cost of care go up?"

A working demo of the approach, not a product pitch. Pick a question: each answer shows the governed metrics it used, the data checks it ran, and where a person has to decide. It builds on what I've already started at Magnit with a Snowflake Cortex pilot over governed KPI views.

THE QUESTION THAT MATTERS MOST Did the intervention actually improve utilization, clinical outcomes and financial performance?
Utilization−4.2 ptsER visits vs matched comparison
Clinical outcomes+3.1 ptsHbA1c testing (HEDIS); readmissions unchanged
Financial performance$0.9Mnet realized value after $0.5M program cost

Baseline → intervention → outcome → attribution → learn. Synthetic figures; the method is the point.

04 · How I'd lead it at your organization

Build the capability, not another dashboard

Start with the decision leaders need to make. Build reusable analytics and data products around it. Use predictive models where they improve prioritization, and AI where it makes governed evidence easier to explore. Then connect the insight to an accountable workflow and measure whether it created value.

Capability before vendor

Start with the decision to improve, then map existing or new technology to it.

Reuse before rebuild

Use the strategic platforms the organization already pays for when they meet the need.

Data products over silos

Trusted member, provider, cost, quality and authorization products serve many consumers.

Value before scale

Every analytics or AI use case has an owner, a baseline, a target and a way to measure it.

DAYS 1–30

Listen and inventory

  • Meet finance, actuarial, clinical, network and pharmacy leads
  • Inventory platforms, data assets, metric definitions and skills
  • Find where PMPM numbers disagree today
DAYS 31–60

Agree the model

  • One cost-driver taxonomy, signed off by finance and actuarial
  • Governed PMPM, utilization and unit-cost definitions
  • Pick one high-value driver path, such as ER or specialty Rx
DAYS 61–90

Prove one thin slice

  • Signal → decomposition → cohort → owner, on existing BI
  • Conversational investigator on certified metrics only
  • Baseline set so realized value can be measured
Idea 01 · Conversational intelligence Proposed

An intelligence layer on the reporting you already own

Health plans already have warehouses, semantic models and dashboards. What they lack is a fast, trusted path from "this number moved" to "here is why, here is what we can influence, and here is who owns it." The layer below adds that path without replacing a single platform.

Already in place

Sources & platform

  • Claims, pharmacy, eligibility
  • Provider, contracts, prior auth
  • EHR / FHIR, labs, SDOH
  • Snowflake, Databricks, Fabric, BigQuery
Already in place

Semantic model & BI

  • Certified PMPM, utilization, unit cost
  • Power BI, Tableau, Looker
  • dbt / semantic-layer metrics
  • Row-level security
What gets added

Conversational intelligence

  • Understands the question
  • Uses only governed metrics
  • Decomposes the trend, cites evidence
  • Flags data-quality gaps
  • Suggests the next analysis and owner
Who uses it

Decision makers

  • CFO, actuarial, finance
  • Analysts (hours back)
  • Care & utilization management
  • Network and pharmacy leads
  • Member navigation teams
No free-form SQL on PHI Answers cite certified metrics Minimum-necessary, role-based access Lineage logged on every answer Human review before action

Members

  • Earlier help. Rising-risk members are found while a follow-up visit can still prevent an ER trip.
  • Lower out-of-pocket. Navigation toward appropriate, lower-cost sites of care.
  • Faster answers. Prior authorization treated as a measured journey, with turnaround tracked.

The health plan

  • Trend explained in minutes, not a two-week analyst cycle.
  • Opportunity separated from savings, so finance trusts the number.
  • AI value that is measured, with a baseline and owner per use case.
  • Interoperability readiness for the CMS 2027 API requirements.

Providers

  • Shared facts for practice-pattern and value-based contract conversations.
  • Less authorization friction through clear requirements and reasons.
  • Fewer surprises at reconciliation, because cost and quality are read together.
Idea 02 · Trusted Metrics Foundation Proposed

One trusted number for PMPM, utilization, quality and outcomes, in every tool.

Technically: a platform-independent semantic layer

Today a health plan's most important definitions, such as PMPM, utilization per 1,000 and HEDIS rates, are locked inside individual BI files. Each tool computes its own version, every migration means rewriting them, and AI can't read them. A Trusted Metrics Foundation keeps the business logic in one governed place that any warehouse can run and any analytics tool can query.

Six teams ask the same question: "What was commercial allowed PMPM last year?"

Any data platform
  • Snowflake
  • Databricks
  • BigQuery
  • Microsoft Fabric
  • Redshift · Postgres
Trusted Metrics Foundation
  • Metrics and dimensions as code, versioned in git
  • Compiled to each platform's own SQL
  • PHI and row-level policies defined once
  • Certification, owners and lineage
  • Caching for speed and cost
Any consumer
  • BI: Power BI, Tableau, Looker
  • Excel and Sheets
  • Python and notebooks
  • Apps via REST / GraphQL
  • AI agents via MCP
metrics/allowed_pmpm.ymlillustrative, OSI / MetricFlow style
metric:
  name: allowed_pmpm
  label: Allowed PMPM
  owner: finance-actuarial
  status: certified
  version: 3.2
  type: ratio
  numerator: total_allowed_amount   # incurred basis, IBNR-completed
  denominator: member_months
  filter: line_of_business = 'commercial'
  time: incurred_month
  dimensions: [market, product, service_category,
               provider_group, cohort]
  policies:
    phi: aggregate_only             # no member rows in BI
    min_cell_size: 11               # small-cell suppression

Start with the metrics payers argue about most

Member monthsAllowed & paid PMPMUtilization per 1,000Cost per unitIBNR-completed costMedical loss ratioRisk score (HCC)ER visits per 1,00030-day readmissionsHEDIS measuresPDC adherencePrior auth turnaround

Each one gets an owner, a certification status, a version history and a test suite. When actuarial changes the IBNR method, every dashboard, extract and AI answer changes with it the same day.

No platform lock-in

Switching BI tools or warehouses means repointing connections, not rewriting hundreds of measures.

One number everywhere

The board deck, the actuarial filing, the dashboard and the AI answer all agree.

AI-ready by design

Agents read certified definitions instead of guessing from table names. Idea 01's investigator runs on this foundation.

Govern PHI once

Access rules and small-cell suppression travel with the metric, whatever tool asks for it.

  1. InventoryFind every place PMPM and its siblings are defined, and where the numbers disagree.
  2. CodifyDefine the top 20 healthcare metrics as code with finance, actuarial and quality sign-off.
  3. ConnectPoint two BI tools and the AI investigator at the layer; reconcile against today's reports.
  4. RetireRemove duplicate logic from BI files as each team moves over.

Built on open semantic-layer standards, so the foundation itself is not a new lock-in: the Open Semantic Interchange (OSI) spec, published under Apache 2.0 with Snowflake, Salesforce, dbt Labs and Databricks among its backers, and MetricFlow, open-sourced under Apache 2.0 in October 2025.

Use cases

Start with a business question

Each use case applies the same model to a different decision. Cost of care is the flagship proof of concept; population health is the second deep dive.

Why now

What payers are up against in 2026–2027

Affordability pressure is coming from several directions at once. Isolated reports cannot keep up with that; a shared model that decomposes cost and connects it to action can.

9%

Projected 2027 group medical cost trend

8.5% for the individual market; the highest in nearly two decades. Survey of 27 health plans covering 103M+ employer-sponsored members.

PwC · Behind the Numbers 2027
70%

of plans rank provider AI coding tools a top-3 inflator

Providers are using AI to optimize revenue. Payers need intelligence that can see the effect in their own claims.

PwC · Behind the Numbers 2027
62.6%

growth in behavioral-health claims utilization

From 2018 to 2024, listed among the major inflators alongside pharmacy and reimbursement pressure.

PwC · Behind the Numbers 2027
85% / 38%

expect GLP-1 and specialty-drug margin impact / feel well prepared

Health-plan finance leaders see the pharmacy problem coming but lack the capability to manage it.

Deloitte · 2026 Healthcare CFO Survey
18%

of AI scalers consistently measure AI's financial impact

44% of organizations are scaling AI, yet few can show what it returned in revenue or cost savings.

Deloitte · 2026 Healthcare CFO Survey
Jan 1, 2027

CMS prior authorization and access APIs due

Impacted payers must support Patient Access, Provider Access, Payer-to-Payer and Prior Authorization APIs under CMS-0057-F.

CMS · Interoperability & Prior Auth Final Rule
So what

A 9% trend does not mean 9% is addressable. The capability that matters is separating utilization, unit cost, population mix and service mix, locating where each is concentrated, and proving which interventions changed the outcome.

Deep dive · Cost of care

Cost driver explorer

Click any branch. The tree breaks an 8.2% PMPM increase into the categories that caused it, measured in percentage points of total growth, then shows whether each one is about more care, pricier care, or a different population.

Utilization

How often care happens: visits, admissions, procedures, scripts per 1,000 members. Is it clinically expected, access-related, or potentially avoidable?

Unit cost

Allowed cost per visit, admission, procedure or script. Reimbursement, facility mix, network status and contract changes all show up here.

Population / risk mix

Age, morbidity, geography and product mix. Separating this stops leaders from treating every increase as an operational failure.

Service mix

What care is delivered and where: specialty drugs, complex procedures, or a shift from office (POS 11) to hospital outpatient (POS 22).

From signal to action

Cost is a journey, not a row in a claims table

The same rising ER line in the tree is made of real member journeys. Seeing them that way shows where an earlier, cheaper, better intervention was possible.

Maria · synthetic member
57 · Type 2 diabetes · hypertension · illustrative only
Risk trajectoryRising
JAN
PCP visit$180
MAR
Diabetes dx$450
MAY
Missed follow-upcare gap
JUL
ER visit$3,200
SEP
Admission$18,500
NOV
Follow-up$420
Signals in the dataNew diagnosis, missed follow-up, 60-day gap in metformin fills, then an ER claim.
Where it could routeRisk stratification → care-manager outreach → pharmacy adherence review → transition-of-care follow-up.
GuardrailAnalytics surfaces the signal. Clinical and operational teams decide whether intervention is appropriate.
  1. SignalPMPM, utilization or quality moves outside its expected range.
  2. InvestigateLocate it across medical, pharmacy, market, product and population.
  3. DecomposeSplit utilization, unit cost, risk mix, service mix and network effects.
  4. Root causeTrace to service, provider, facility, condition, drug or cohort.
  5. AddressabilityExpected, appropriate, influenceable, or potentially avoidable?
  6. InterveneRoute to clinical, network, pharmacy, member or finance owners.
  7. MeasureExpected vs actual cost, quality, utilization and member outcomes.
  8. LearnScale, redesign or stop; refine rules and models.
Gate 1 · Is the signal real?

Check claims completeness and IBNR, membership shifts, seasonality and metric definitions before escalating.

Gate 2 · Is it addressable?

Separate clinically appropriate or structural cost from what the plan can realistically influence.

Gate 3 · Did we create value?

Report realized impact against a baseline, never identified opportunity as savings. Read cost with quality.

Use case 02 · Population health & risk

From a whole membership to the members a program can help

Turn a broad population into a clinically and operationally meaningful priority cohort, then measure whether intervention changed utilization, outcomes and cost. Click a stage.

Why is this cohort emerging?

Analytics has to continue after the prediction

  1. ObserveLongitudinal member signals
  2. StratifyRisk and cohort analytics
  3. ValidateClinical and operational context
  4. InterveneHuman-led program workflow
  5. MeasureClinical, utilization and financial outcomes
AI's role

The investigator can summarize governed cohort evidence, compare segments and suggest the next analytical question, for example "Why are these members moving into rising risk?" Program eligibility and clinical decisions stay with people.

All member counts are synthetic and use the same 117.4K-member plan as the rest of this page. This shows an analytics operating model, not clinical decision-making.

Decide before you fund

What-if intervention simulator

Test an intervention hypothesis against its addressable opportunity before it becomes a business case. Move the sliders.

Scenario

Share of the addressable opportunity the program is expected to remove at full run-rate.
Staff, vendor, outreach and member incentives.
Year-one value assumes a linear ramp.

Modeled result

Quality (HEDIS)ReadmissionsAccessMember experienceClinical appropriateness
Identified opportunity$64.0M
Addressable$42.0M
Intervention population$22.0M
Projected value$8.5M

Identified opportunity is not realized savings. Synthetic figures.

Deep dive · Target architecture

Capability first, vendor second

The business model, data products and metric definitions stay stable. The technology underneath can change with strategy, existing investment, skills and cost. Reuse strategic platforms; add technology only where there is a real gap.

  1. Data sourcesClaims · pharmacy · eligibility · provider · EHR · labs · prior auth · SDOH · contracts
  2. Integration & interoperabilityBatch · APIs · FHIR · HL7 · X12 EDI · CDC · streaming · data quality
  3. Data platformLakehouse · warehouse · streaming · metadata · security
  4. Healthcare data productsMember · provider · claims · pharmacy · cost · quality · authorization · network
  5. Semantic & intelligenceGoverned metrics · ontology · reusable models · APIs · Trusted Metrics Foundation
  6. AI & advanced analyticsForecasting · anomaly detection · GenAI investigator · agents
  7. Decisions & workflowsCare · provider · network · pharmacy · prior auth · outreach · finance
  8. Outcomes & learningCost · quality · experience · ROI · feedback to models

Member 360

Identity, eligibility, risk, conditions, utilization, cost, care gaps, engagement.

Provider 360

Identity, specialty, network, contract, cost, quality, referrals, outcomes.

Claims & cost

Claim lines, allowed and paid, PMPM, utilization, episodes, attribution.

Pharmacy

Drug spend, specialty, therapeutic class, adherence, prescribers, site of care.

Quality

Measures, care gaps, preventive care, readmissions, outcomes.

Authorization

Requests, decisions, turnaround, reasons, appeals, downstream utilization.

Network & contracts

Status, leakage, reimbursement, fee schedules, contract terms.

Risk & cohorts

Stratification, disease cohorts, emerging risk, intervention populations.

Technology options by ecosystem
CapabilityMicrosoftAWSGoogleIndependent / hybrid
StorageADLS / OneLakeS3Cloud StorageObject storage
Data platformFabric / DatabricksRedshift / DatabricksBigQuerySnowflake / Databricks
TransformationFabric / dbtGlue / dbtDataform / dbtdbt / Spark
OrchestrationFabric / ADFMWAA / Step FunctionsComposerAirflow / Dagster
StreamingEvent HubsKinesis / MSKPub/SubKafka / Confluent
BI & semanticPower BIQuickSightLookerTableau / dbt semantic layer
AI / MLAzure AISageMaker / BedrockVertex AIDatabricks / model ecosystem
GovernancePurviewLake FormationDataplexCollibra / Alation
MDM / identityEnterprise choice based on the existing ecosystem, e.g. Informatica, Reltio or current MDM
Batch

Claims history, financial reconciliation, trend reporting, quality calculations. Daily latency is fine.

API / near real time

Member and provider apps, authorization workflows, FHIR access APIs.

Event driven

Admissions, discharges, authorization status changes: events where faster awareness changes a decision.

PHI minimum necessaryRBAC / ABACEncryption & maskingData quality SLAsLineage: source → metric → decisionAuditRetentionAI oversight proportional to risk
Let's talk

Let's build the next healthcare intelligence capability.

I'm interested in leading teams that connect healthcare data, advanced analytics and responsible AI to better clinical, operational and financial decisions. If you're building that capability, I'd welcome the conversation.

Dhaval Shah · Healthcare Data, Analytics & AI Leader